Greenhouse Funds to Aid 'High Risk, High Reward' Research

BioAdvance is set to unveil its third round of investments, which will provide roughly $3.5 million to seven local life sciences researchers or companies. "About half are involved in new therapeutic products and half are working on diagnostics or devices," said Barbara Schilberg, BioAdvance's CEO.

Philadelphia Business Journal (http://www.bizjournals.com/philadelphia/stories/2005/01/24/story7.html)